EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Estimate the relationship between CXCR4-SDF-1 axis and inhibitory molecules (CTLA4 and PD-1) in patients with colon cancer

Suhad D Abdul-Huseen, Hazima M Alabassi

Narra J · 2024

DOI: 10.52225/narra.v4i3.992 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Narra J, 2024. Verfasst von Suhad D Abdul-Huseen und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Education for Pure Science Ibn Al-Haitham, University of Baghdad, Baghdad, Iraq. Hauptthemen laut MEDLINE: Receptors, CXCR4, Chemokine CXCL12, Colonic Neoplasms, Programmed Cell Death 1 Receptor. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Colon neoplasia is one of the major malignancies in industrialized countries due to their Western-style food habits. It accounts for more than 50% of the population developing adenomatous polyps by the age of 70 years, but 10% of cancers in developed countries. The aim of this study was to evaluate the pathological role of the C-X-C chemokine receptor type 4/stromal-derived factor 1 axis (CXCR4-SDF-1 axis), and the inhibitory molecules PD-1 and cytotoxic T-lymphocyte associated protein 4 (CTLA-4) in postoperative colon cancer patients undergoing treatment with chemotherapy (oxaliplatin and capecitabine) and estimate the correlation between these studied factors to deeply understand the basic mechanisms and potential diagnostic or therapeutic effects. The study involved 90 patients, including 50 colon cancer patients (male and female, aged 35–65) diagnosed by oncologists at Al-Ramadi Hospital, Ramadi, Iraq. All patients underwent surgical resection and received four cycles of chemotherapy with oxaliplatin (85 mg every 21 days) and capecitabine (6 grams daily for 21 days). Additionally, 40 age- and sex-matched individuals served as the control group. For each participant, CXCR4 and SDF-1 levels were measured using ELISA and the gene expression of CTLA-4 and PD-1 were measured using RT-PCR. The colon cancer patient group showed significantly lower levels of CXCR4 and SDF-1 compared to control groups (0.163±0.012 vs 0.376±0.025 pg/mL and 0.376±0.025 vs 0.699±0.110 pg/mL, respectively, both had p=0.001). Moreover, the colon cancer patient group had significantly lower expression of PD-1 and CTLA4 compared to control group (0.102±0.029-fold vs 1.199±0.391-fold, p=0.02; and 0.302±0.140-fold vs 1.441±0.334-fold, p=0.008, respectively). In conclusion, the results suggest that CXCR4 and SDF-1 appear promising as diagnostic markers for distinguishing colon cancer patients from healthy conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, CXCR4Chemokine CXCL12Colonic NeoplasmsProgrammed Cell Death 1 ReceptorCTLA-4 AntigenHumansMaleFemaleMiddle AgedAgedAdultOxaliplatinCapecitabine

Stichwörter der Autor:innen

CTLA4CXCR4PD-1SDF-1colon cancer

Substanzen

Receptors, CXCR4Chemokine CXCL12Programmed Cell Death 1 ReceptorCXCR4 protein, humanCTLA-4 AntigenCXCL12 protein, humanPDCD1 protein, humanCTLA4 protein, humanOxaliplatinCapecitabine

Autor:innen und Institutionen

  • Department of Biology, College of Education for Pure Science Ibn Al-Haitham, University of Baghdad, Baghdad, Iraq.

Zitieren

APA

Abdul-Huseen, S. D., & Alabassi, H. M. (2024). Estimate the relationship between CXCR4-SDF-1 axis and inhibitory molecules (CTLA4 and PD-1) in patients with colon cancer. Narra J. https://doi.org/10.52225/narra.v4i3.992

Vancouver

Abdul-Huseen SD, Alabassi HM. Estimate the relationship between CXCR4-SDF-1 axis and inhibitory molecules (CTLA4 and PD-1) in patients with colon cancer. Narra J. 2024. doi:10.52225/narra.v4i3.992

BibTeX
@article{AbdulHuseen2024,
  author = {Abdul-Huseen, Suhad D and Alabassi, Hazima M},
  title = {Estimate the relationship between CXCR4-SDF-1 axis and inhibitory molecules (CTLA4 and PD-1) in patients with colon cancer},
  journal = {Narra J},
  year = {2024},
  doi = {10.52225/narra.v4i3.992}
}
Kostenlos starten →